Are Ketogenic Diets Promising for Alzheimer’s Disease? A Translational Review
This 2020 translational review analyzed 22 studies—11 preclinical and 11 clinical—evaluating the impact of ketogenic diets (KDs) and medium-chain triglyceride (MCT) supplementation on Alzheimer’s disease (AD). Animal studies showed consistent improvements in cognitive and motor outcomes, reductions in amyloid and tau pathology, and enhanced mitochondrial function. Human trials, though varied